These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
120 related articles for article (PubMed ID: 38301732)
1. Equine grass sickness is associated with major abnormalities in the ultrastructure of skeletal neuromuscular junctions. McGorum BC; Davey T; Dosi MCM; Keen JA; Morrison LR; Pirie RS; Shaw DJ; Harris JB Equine Vet J; 2024 Feb; ():. PubMed ID: 38301732 [TBL] [Abstract][Full Text] [Related]
2. The association of Clostridium botulinum type C with equine grass sickness: a toxicoinfection? Hunter LC; Miller JK; Poxton IR Equine Vet J; 1999 Nov; 31(6):492-9. PubMed ID: 10596931 [TBL] [Abstract][Full Text] [Related]
3. Equine grass sickness, but not botulism, causes autonomic and enteric neurodegeneration and increases soluble N-ethylmaleimide-sensitive factor attachment receptor protein expression within neuronal perikarya. McGorum BC; Scholes S; Milne EM; Eaton SL; Wishart TM; Poxton IR; Moss S; Wernery U; Davey T; Harris JB; Pirie RS Equine Vet J; 2016 Nov; 48(6):786-791. PubMed ID: 26640078 [TBL] [Abstract][Full Text] [Related]
4. Preliminary study of mucosal IgA in the equine small intestine: specific IgA in cases of acute grass sickness and controls. Nunn FG; Pirie RS; McGorum B; Wernery U; Poxton IR Equine Vet J; 2007 Sep; 39(5):457-60. PubMed ID: 17910272 [TBL] [Abstract][Full Text] [Related]
5. Neuronal chromatolysis in the subgemmal plexus of gustatory papillae in horses with grass sickness. McGorum BC; Pirie RS; Shaw D; Macintyre N; Cox A Equine Vet J; 2016 Nov; 48(6):773-778. PubMed ID: 26518231 [TBL] [Abstract][Full Text] [Related]
6. Equine grass sickness (a multiple systems neuropathy) is associated with alterations in the gastrointestinal mycobiome. McGorum BC; Chen Z; Glendinning L; Gweon HS; Hunt L; Ivens A; Keen JA; Pirie RS; Taylor J; Wilkinson T; McLachlan G Anim Microbiome; 2021 Oct; 3(1):70. PubMed ID: 34627407 [TBL] [Abstract][Full Text] [Related]
7. An epidemiological study of risk factors associated with the recurrence of equine grass sickness (dysautonomia) on previously affected premises. Newton JR; Hedderson EJ; Adams VJ; McGorum BC; Proudman CJ; Wood JL Equine Vet J; 2004 Mar; 36(2):105-12. PubMed ID: 15038431 [TBL] [Abstract][Full Text] [Related]
8. Systemic antibodies to Clostridium botulinum type C: do they protect horses from grass sickness (dysautonomia)? Hunter LC; Poxton IR Equine Vet J; 2001 Nov; 33(6):547-53. PubMed ID: 11720025 [TBL] [Abstract][Full Text] [Related]
9. Equine grass sickness is associated with low antibody levels to Clostridium botulinum: a matched case-control study. McCarthy HE; French NP; Edwards GB; Poxton IR; Kelly DF; Payne-Johnson CE; Miller K; Proudman CJ Equine Vet J; 2004 Mar; 36(2):123-9. PubMed ID: 15038434 [TBL] [Abstract][Full Text] [Related]
10. Equine grass sickness: epidemiology, diagnosis, and global distribution. Wylie CE; Proudman CJ Vet Clin North Am Equine Pract; 2009 Aug; 25(2):381-99. PubMed ID: 19580947 [TBL] [Abstract][Full Text] [Related]
11. Outbreaks of equine grass sickness in Hungary. Schwarz B; Brunthaler R; Hahn C; van den Hoven R Vet Rec; 2012 Jan; 170(3):75. PubMed ID: 22124026 [TBL] [Abstract][Full Text] [Related]
12. Designing a field trial of an equine grass sickness vaccine: A questionnaire-based feasibility study. Ireland JL; McGorum BC; Proudman CJ; Newton JR Vet J; 2016 Jul; 213():64-71. PubMed ID: 27240918 [TBL] [Abstract][Full Text] [Related]
13. Overexpression of Dok-7 in skeletal muscle enhances neuromuscular transmission with structural alterations of neuromuscular junctions: Implications in robustness of neuromuscular transmission. Eguchi T; Tezuka T; Fukudome T; Watanabe Y; Sagara H; Yamanashi Y Biochem Biophys Res Commun; 2020 Feb; 523(1):214-219. PubMed ID: 31848047 [TBL] [Abstract][Full Text] [Related]
14. The neurology and enterology of equine grass sickness: a review of basic mechanisms. Cottrell DF; McGorum BC; Pearson GT Neurogastroenterol Motil; 1999 Apr; 11(2):79-92. PubMed ID: 10320588 [TBL] [Abstract][Full Text] [Related]
15. Equine grass sickness in Scotland: a case-control study of signalment- and meteorology-related risk factors. Wylie CE; Shaw DJ; Fordyce FM; Lilly A; McGorum BC Equine Vet J; 2014 Jan; 46(1):64-71. PubMed ID: 23662745 [TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of antibotulinum neurotoxin type C antibodies in horses in Israel. Steinman A; Kachtan I; Levi O; Shpigel NY Equine Vet J; 2007 May; 39(3):232-5. PubMed ID: 17520974 [TBL] [Abstract][Full Text] [Related]
17. Equine grass sickness in Scotland: A case-control study of environmental geochemical risk factors. Wylie CE; Shaw DJ; Fordyce FM; Lilly A; Pirie RS; McGorum BC Equine Vet J; 2016 Nov; 48(6):779-785. PubMed ID: 26227429 [TBL] [Abstract][Full Text] [Related]
18. Effects of equine grass sickness on sympathetic neurons in prevertebral and paravertebral ganglia. Shotton HR; Lincoln J; McGorum BC J Comp Pathol; 2011 Jul; 145(1):35-44. PubMed ID: 21457994 [TBL] [Abstract][Full Text] [Related]
19. Neurodegeneration in equine grass sickness is not attributable to niacin deficiency. McGorum BC; Jago RC; Cillan-Garcia E; Pirie RS; Keen JA; Reardon RJM; Saffu PY; Miller NJ Equine Vet J; 2017 Jul; 49(4):445-447. PubMed ID: 27529289 [TBL] [Abstract][Full Text] [Related]
20. The role of quantitative electromyography (EMG) in horses suspected of acute and chronic grass sickness. Wijnberg ID; Franssen H; Jansen GH; van den Ingh TS; van der Harst MR; van der Kolk JH Equine Vet J; 2006 May; 38(3):230-7. PubMed ID: 16706277 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]